Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osman Moneer

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Laryngoscope Investigative Otolaryngology|February 24, 2025
Voting Trends Among Otolaryngology-Head and Neck Surgery TraineesAlexandra T Bourdillon, Osman Moneer, Kevin Y Zhan, et al.
BMJ (Clinical Research Ed.)|May 10, 2022
Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological studyOsman Moneer, Garrison Daly, Joshua J Skydel, et al.
JAMA Internal Medicine|October 3, 2022
Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016Beatrice L Brown, Mayookha Mitra-Majumdar, Jonathan J Darrow, et al.
JAMA Network Open|April 15, 2025
Research Derived From Medicare's Coverage With Evidence Development ProgramGuneet S Janda, Osman Moneer, Maryam Mooghali, et al.
JAMA Health Forum|November 26, 2025
Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare ReimbursementOsman Moneer, Kushal T Kadakia, Sanket S Dhruva, et al.
Health Affairs (Project Hope)|November 19, 2020
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19Aaron S Kesselheim, Jonathan J Darrow, Martin Kulldorff, et al.
JAMA Surgery|February 25, 2026
Therapeutic Benefit Ratings for FDA Breakthrough-Designated DevicesKushal T Kadakia, Christine M Swoboda, Osman Moneer, et al.
Drug Safety|February 19, 2022
New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the EvidenceOsman Moneer, Beatrice L Brown, Jerry Avorn, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Laryngoscope Investigative Otolaryngology|February 24, 2025
Voting Trends Among Otolaryngology-Head and Neck Surgery TraineesAlexandra T Bourdillon, Osman Moneer, Kevin Y Zhan, et al.
BMJ (Clinical Research Ed.)|May 10, 2022
Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological studyOsman Moneer, Garrison Daly, Joshua J Skydel, et al.
JAMA Internal Medicine|October 3, 2022
Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016Beatrice L Brown, Mayookha Mitra-Majumdar, Jonathan J Darrow, et al.
JAMA Network Open|April 15, 2025
Research Derived From Medicare's Coverage With Evidence Development ProgramGuneet S Janda, Osman Moneer, Maryam Mooghali, et al.
JAMA Health Forum|November 26, 2025
Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare ReimbursementOsman Moneer, Kushal T Kadakia, Sanket S Dhruva, et al.
Health Affairs (Project Hope)|November 19, 2020
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19Aaron S Kesselheim, Jonathan J Darrow, Martin Kulldorff, et al.
JAMA Surgery|February 25, 2026
Therapeutic Benefit Ratings for FDA Breakthrough-Designated DevicesKushal T Kadakia, Christine M Swoboda, Osman Moneer, et al.
Drug Safety|February 19, 2022
New Drug Postmarketing Requirements and Commitments in the US: A Systematic Review of the EvidenceOsman Moneer, Beatrice L Brown, Jerry Avorn, et al.
Pageof 2